Trials / Unknown
UnknownNCT04113941
Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder
A Randomized, Double-Blind, Placebo-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is for patients who have idiopathic overactive bladder symptoms. This study will evaluate efficacy and safety of Neuronox® against placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neuronox | intradetrusor injection |
| DRUG | Placebo | intradetrusor injection |
Timeline
- Start date
- 2019-08-23
- Primary completion
- 2020-04-15
- Completion
- 2021-08-01
- First posted
- 2019-10-03
- Last updated
- 2020-07-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04113941. Inclusion in this directory is not an endorsement.